Citi Initiates Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $60

Moomoo News18:31 ET · Ratings

Structure Draws New Buy at Citi on Oral Obesity Drug Pipeline

Seeking AlphaMay 2 10:31 ET

Citigroup Initiates Coverage on Structure Therapeutics With Buy Rating, $60 Price Target

MT NewswiresMay 2 07:36 ET · Ratings

Viking Among Notable Gainers as Pfizer Raises Deal Prospects

Seeking AlphaApr 29 15:26 ET

H.C. Wainwright Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $80

Moomoo NewsApr 22 19:32 ET · Ratings

Structure Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow JonesApr 22 06:26 ET · Ratings